Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
This report contains market size and forecasts of Finasteride Oral Tablet in global, including the following market information:
Global Finasteride Oral Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Finasteride Oral Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Finasteride Oral Tablet companies in 2021 (%)
The global Finasteride Oral Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Finasteride Oral Tablet include Merck, Accord Healthcare UK, Relonchem, Sandoz, Teva Generics, Cipla, Dr. Reddy, Aurobindo Pharma and Henan Topfond, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Finasteride Oral Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Finasteride Oral Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Finasteride Oral Tablet Market Segment Percentages, by Type, 2021 (%)
1mg Tablet
5mg Tablet
Global Finasteride Oral Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Finasteride Oral Tablet Market Segment Percentages, by Application, 2021 (%)
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Global Finasteride Oral Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Finasteride Oral Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Finasteride Oral Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Finasteride Oral Tablet revenues share in global market, 2021 (%)
Key companies Finasteride Oral Tablet sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Finasteride Oral Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.